Why Is Bone Biologics Stock Surging On Friday?

Bone Biologics Corporation (NASDAQ:BBLG) stock is trading higher on Friday, with a session volume of 17.22 million compared to the average volume of 38.795K as per data from Benzinga Pro.

The company filed a patent application with the U.S. Patent and Trademark Office (USPTO) for its preclinical NELL-1 protein.

Bone Biologics is focusing development efforts for its bone graft substitute product on bone regeneration in spinal fusion procedures. It additionally has rights to trauma and osteoporosis applications.

The patent application is directed to compositions of rhNELL-1 polypeptide and uses thereof for treating bone conditions.

“This patent application marks a major ...